Source: Contract Pharma

Pharm-Olam: Cato SMS, Pharm-Olam Merge to Create Global Biopharma Services Company

Newly combined company positioned to serve small and mid-sized biopharmaceutical companies.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
500-1.0K
Robert J. Davie's photo - CEO of Pharm-Olam

CEO

Robert J. Davie

CEO Approval Rating

83/100

Read more